In the second part of the study, an HIF-1α inhibitor YC-1 was added and we found that a decrease in the HIF-1α expression resulted in a decrease in VEGF expression and an increase in the permeability of bladder cancer cells during hypoxia. Here, VEGFA is linked to urinary bladder cancer.